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Abstract Increased demand for genetic counseling services
necessitates exploring alternatives to in-person counseling.
Telephone counseling is a less time-consuming and more
cost-effective alternative. So far there is insufficient evi-
dence to support a pre-counseling telephone model. This
randomized questionnaire study aims to evaluate the onco-
genetic counseling process and to compare the impact of the
initial part of the oncogenetic counseling, when conducted
via telephone versus in-person. The aspects of evaluations
were: patients’ expectations, satisfaction and experiences of
genetic counseling, worry for developing hereditary cancer
and health related quality of life. A total of 215 participants
representing several cancer syndromes were randomized to
counseling via telephone or in-person. The questionnaires
were completed before and after oncogenetic nurse coun-
seling, and 1 year after the entire counseling process.
Overall, a high satisfaction rate with the oncogenetic coun-
seling process was found among the participants regardless
of whether the oncogenetic nurse counseling was conducted
by telephone or in-person. The results show that a consid-
erable number of participants experienced difficulties with
the process of creating a pedigree and dissatisfaction with
information on surveillance and prevention. Affected par-
ticipants reported lower levels in most SF-36 domains
compared to non-affected and both groups reported lower
levels as compared to a Swedish reference group. The results
indicate that telephone pre-counseling works as well as
in-person counseling. Emotional support during genetic
counseling and information on recommended cancer pre-
vention and surveillance should be improved.
Keywords Hereditary cancer  Oncogenetic in-person
counseling  Oncogenetic telephone counseling 
Cancer worry  Oncogenetic nurse
Introduction
Studies on patients receiving genetic counseling at hered-
itary cancer clinics have to a large extent indicated high
levels of satisfaction [1–5]. There are, however, areas of
lesser satisfaction with oncogenetic counseling such as
emotional support and understanding one’s own cancer risk
[1, 3, 5, 6].
A number of publications discuss genetic counseling via
telephone versus traditional in-person counseling. There is
an agreement that in order to meet the increased demand
for genetic services in general, and to gain better access in
rural areas in particular, alternatives to in-person genetic
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counseling must to be explored [7–11]. Patient advantages
with telephone versus in-person counseling could be
immediate access to services, increased control over the
interaction, privacy and anonymity [7] and avoidance of
stress and expense [9, 12]. One disadvantage is lack of non-
verbal cues [7]. From both the patient and the health-care
point of view, costs can be reduced with telephone coun-
seling [9, 13].
While post-result counseling has been tested and found
to convey a high satisfaction level regardless whether it
was conducted by telephone or in-person [13, 14], there is
little evidence to support a pre-counseling telephone model
[10, 11, 15].
This randomized questionnaire study aims at evaluating
the counseling process in general at the department of
Clinical Genetics at Karolinska University Hospital and to
analyze the impact of the initial part of the counseling, the
oncogenetic nurse counseling (OGNC), conducted via
telephone versus in-person. The aspects of the evaluations
are: patients’ expectations of genetic counseling, satisfac-
tion and experiences with the different parts of the coun-
seling process, worry for developing hereditary cancer and
health related quality of life. The current study is part of a
more comprehensive exploration and results from risk
perception in the same cohort of participants have previ-
ously been published [16]. The overall intention of this
study is to improve and facilitate the counseling process in
order to meet patients’ needs.
Materials and methods
The standardized oncogenetic counseling procedure
at the Karolinska University Hospital
Patients in the Stockholm County are referred to oncoge-
netic counseling by their general practitioners. The coun-
seling process is divided into two parts. During the first
part, the OGNC, patients are informed about the counseling
procedure and familial cancer in general. A family pedi-
gree is established in collaboration with the patient and
cancer diagnoses in the family are confirmed through
medical records and/or death certificates. OGNC is given
either via telephone or in-person. Both OGNC groups are
pre-informed of the content of the discourse and of the
scheduled time and all OGNC is performed without dis-
turbances and with ample time. During the second part of
the counseling process the patients have a personal meeting
with a physician including a review of: the family history
of cancer, risk estimation, possibility of genetic testing,
surveillance and prevention. All patients receive a letter
summarizing the outcome after the completed counseling
process.
Study procedure
All patients with no previous genetic counseling in the
family referred to the Department of Clinical Genetics at the
Karolinska University Hospital during the course of 1 year
were eligible to participate in a questionnaire study. A total
of 309 patients fulfilled the criteria and were consecutively
randomized to OGNC via telephone or in-person 1:1. They
received a letter with study information and an invitation to
participate. The letter also included the first of three ques-
tionnaires and a time for OGNC either via telephone or in-
person. Patients willing to participate and who responded to
at least one questionnaire were included in the study (par-
ticipants). The second questionnaire was sent to the partici-
pants after completion of OGNC and physician counseling,
and the third questionnaire was distributed 1 year after
completing the entire counseling process. The question-
naires were sent together with a prepaid return envelope. The
questionnaire data was collected during a study period of
3 years. One and the same nurse (UP) conducted all OGNC
whereas seven physicians were involved in the second part of
the counseling process during the study period.
Study and questionnaire design
The questionnaires were designed jointly by a geneticist
(AL), a psychologist (YB), an oncogenetic nurse (UP) and a
graduate student of public health (GL). The questionnaires
were tested on four patients and found feasible for the study.
No formal reliability testing or validation was performed.
The participants were given dissimilar questions regarding
worry for cancer depending on whether or not they were
previously diagnosed with the type of cancer they had a
family history of i.e., ‘‘affected’’ or ‘‘non-affected’’.
The first questionnaire (before OGNC)
The participants were asked to indicate:
1. On whose initiative they were referred to genetic
counseling: their own, a physician’s, a relative’s or
somebody else’s initiative. More than one response
alternative to this item could be chosen.
2. The reason why they attended genetic counseling. The
question was addressed as an open-ended answer
query.
3. Their expectations of genetic counseling. The question
was addressed as an open-ended answer query.
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The second questionnaire (after OGNC)
The participants were asked to evaluate:
1. Their satisfaction with the counseling provided by the
oncogenetic nurse on a four- level scale, from satisfied
to a ‘‘very high extent’’, ‘‘high extent’’, ‘‘low extent’’
to ‘‘not at all satisfied’’.
2. Their experience with the process of creating a
pedigree. Five items were stated: interested in gaining
knowledge of their family, positive to make contact
with relatives, difficult to get information about
relatives, the process took too long and the emotional
difficulty in exposing themselves and their family. The
participants were to use the four-level scale described
above.
3. Their satisfaction regarding contact with the staff at
the oncogenetic clinic. Seven items were to be
evaluated on the four-level scale described above.
The items were: being listened to, being understood,
receiving answers to questions, taking part in decision
making, emotional support, care provided and trust for
the staff.
The third questionnaire (1 year after OGNC)
The participants were requested to evaluate:
1. Their satisfaction regarding contact with the staff at
the oncogenetic clinic. See question nr 3 above in
questionnaire nr 2.
2. Their experience of information and recommendations
received. Four items were to be evaluated on the four-
level scale described above. The items were: under-
standing of information, having received information
on recommended surveillance and prevention, satis-
faction with genetic counseling, and if genetic coun-
seling could be recommended to relatives.
In all three questionnaires participants were to indicate
their level of worry for developing cancer (non-affected) or
developing cancer again (affected). The participants
responded by using a check-box scale ranging from 1 to 7,
from ‘‘not at all worried’’ to ‘‘extremely worried’’.
The Short Form-36 (SF-36) Health Survey was used to
measure the quality of life in participants in all three
questionnaires [17]. SF-36 is composed of 36 items con-
stituting eight health domains related to quality of life
(HRQoL). The three dimensions measuring physical health
are: physical functioning (PF, 10 items), role limitations
due to physical problems (RP, 4 items) and bodily pain
(BP, 2 items). The three mental dimensions are: mental
health (MH, 5 items), role limitations due to emotional
problems (RE, 3 items) and social functioning (SF, 2
items). The two well-being dimensions are: vitality (VT, 4
items) and general health (GH, 5 items). The SF-36 par-
ticipants’ scores were compared to a gender and age-mat-
ched normative population sample (n = 215) formed on
the basis of data from a Swedish population sample
(n = 8,930). Application of this procedure resulted in the
reference values for the population sample presented as
mean value and standard deviation for each of the dimen-
sions. The purpose of the SF-36 in the present study is
threefold: to compare the quality of life between non-
affected and affected participants; to compare the quality of
life between the two OGNC groups and to determine the
impact of time after genetic counseling on the participants’
quality of life.
Ethical aspects
The study was performed in accordance with Swedish law
(2003:460) and approved by the local Ethics Committee,
D:nr 2005/566-31/1.
Statistical analysis
Data analyses were performed with the Statistica 9 and
SPSS program. Descriptive statistics were generated to
display the participants by socio-demographic (age, gen-
der) and medical variables (affected or non-affected) and
for reporting the number of individuals with mean value,
standard deviation (SD) and range. Differences between
non-participants and participants were evaluated using,
Mann–Whitney test for continuous variables (age) and
Pearson’s exact v2 test for categorical variables (gender
and cancer status). Pearson’s exact v2 test was also used to
test difference in satisfaction and experiences of the pedi-
gree process and in experience of information and recom-
mendations. Binary logistic regression analysis was used to
predict effect of cofounders (age, gender and cancer status,
type of counseling i.e. in-person or telephone and on whose
initiative patients were referred to genetic counseling) in
items regarding satisfaction and experience. Wilcoxon
matched pair test was used to analyze differences in worry
for cancer over time in related samples.
Results
Characteristics of participants and non-participants
Among the referred patients 154 were randomized to
OGNC via telephone and 155 to OGNC in-person (Fig. 1).
A total of 28 patients from the first group and 29 from the
second group declined genetic counseling. Of the remain-
ing 253 patients, 19 in each group declined participation in
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the study (non-participants) and continued a standard
genetic counseling procedure. A total of 215 patients (85%
of eligible patients, n = 253), 107 from the in-person
group and 108 from the telephone group returned at least
one of the three questionnaires and were included in the
study (participants) (Fig. 1).
A total of 99% (n = 213), (106 participants randomized
to in-person and 107 to telephone OGNC), of the partici-
pants returned the first questionnaire. Two participants did
not return the first questionnaire but returned the second
and/or the third. The second questionnaire generated 156
responses (69 from the in-person OGNC group and 87 from
the telephone OGNC group). The third questionnaire gen-
erated 141 responses (65 from the in-person OGNC group
and 76 from the telephone OGNC group).
No significant differences were shown between partici-
pants (n = 215) and non-participants (n = 38) with respect
to affected status, gender or age (Table 1).
The non-affected participants, 74% (n = 160), had a
family history of: breast- (n = 104), ovarian- (n = 5),
colorectal- (n = 43) endometrial- (n = 1) or gastric-
(n = 3) cancer. The corresponding types of cancer among
the affected participants, 26% (n = 55), were: breast-
(n = 22), ovarian- (n = 10), colon- (n = 16), endometrial-
(n = 1), gastric- (n = 1) and other- (n = 4) cancer. The
familial cancer history of four non-affected and one
affected participant was unknown, as they never attended
genetic counseling after having answered the first
questionnaire.
No significant difference was found between the two
OGNC groups regarding affected status, types of cancer,
age or gender. In both counseling groups the affected
participants were significantly older than non-affected
(p \ 0.000). In the in-person counseling group the mean
age of non-affected participants was 42.6 years (SD =
11.8, n = 81) and of the affected participants 52.7 years
Fig. 1 Flow chart of participant
recruitment and retention
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(SD = 9.5, n = 26). Corresponding figures for the tele-
phone counseling group were 41.1 (SD = 12.0, n = 79)
and 54.4 years (SD = 12.8, n = 29) respectively.
Questionnaire one
Initiative to referral
A total of 51% (n = 110) of the participants were referred
to oncogenetic counseling on physician’s initiative and
44% (n = 94) on their own, 6% (n = 13) a relative’s and
4% (n = 8) on ‘‘someone else’s’’ initiative. No statistical
significant difference in initiatives of referrals was found
between the two OGNC groups.
Reasons for and expectations of oncogenetic counseling
‘‘A high frequency of cancer in the family’’ was the most
common reason for attending genetic counseling (74%,
n = 158). Other reasons were: ‘‘own cancer’’ (13%, n = 29)
‘‘anxiety’’ (11%, n = 24), ‘‘health problems’’ (10%,
n = 21) and ‘‘for the sake of the family’’ (7%, n = 15).
The three most cited expectations of genetic counseling were
‘‘to obtain information about risk of developing cancer’’ (56%,
n = 119), ‘‘to receive recommendations for preventive
actions’’ (40%, n = 85) and ‘‘to estimate the risk for offspring’’
(15%, n = 33). Expectations were very similar independent of
whose initiative patients were referred, but 11% (n = 12) of the
patients who were ‘‘referred by a physician’’, expressed no
expectations regarding genetic counseling.
Questionnaire two
Satisfaction regarding contact with the oncogenetic nurse
The participants, responding to this item, expressed overall
high satisfaction regarding contact with the oncogenetic
nurse: 94% (n = 144) were completely, 5% (n = 8) par-
tially, 1% (n = 1) not very and 1% (n = 1) not at all sat-
isfied. No statistical significant difference in satisfaction
was shown regarding initiative (v2 = 0.02, p = 0.877),
gender (v2 = 0.29, p = 592), affected status (v2 = 0.75,
p = 0.387), or between the two OGNC groups (v2 = 0.02,
p = 0.882).
Experience of the process of creating a pedigree
Among participants, responding to this item, problems
related to creating a pedigree were found. A total of 20%
(n = 28) of all participants were not interested in gaining
information about their family and 44% (n = 52) were not
comfortable with contacting relatives (Fig. 2). Thirty-seven
percent (n = 52) of the participants had difficulties in
gaining information about relatives and 12% (n = 16)
thought that the process of creating a pedigree took too
long. Of the participants 11% (n = 15) expressed emo-
tional difficulties in exposing themselves and their family.
No statistical significant differences in the experience of
the process of creating a pedigree were found between the
two OGNC groups. Age, gender, affected status or on
whose initiative patients were referred to genetic counsel-
ing did not predict the outcomes.
Questionnaire two and three
Satisfaction regarding contact with the oncogenetic clinic
At both assessment points, participants in both OGNC
groups rated oncogenetic contacts as satisfying to a high
extent (Fig. 3). No significant differences in satisfaction
were found regarding OGNC group in the second or third
questionnaire. Age, gender, affected status or on whose
initiative patients were referred to genetic counseling did
not predict the outcomes.
Table 1 Cancer status, gender and age for participants and non-participants by group
Affected Non-affected Female Male Age (SD) (Range)
Non-participants
In-person (n = 19) 16% (n = 3) 84% (n = 16) 79% (n = 15) 21% (n = 4) 48 (9.9) (31-65) (n = 19)
Telephone (n = 19) 11% (n = 4) 79% (n = 15) 84% (n = 16) 16% (n = 3) 43 (14.4) (23-76) (n = 19)
All (n = 38) 18% (n = 7) 82% (n = 31) 82% (n = 31) 18% (n = 7) 46 (10.2) (23-76) (n = 38)
Participants
In-person (n = 107) 24% (n = 26) 76% (n = 81) 91% (n = 97) 9% (n = 10) 45 (12.0) (16-71) (n = 107)
Telephone (n = 108) 27% (n = 28) 73% (n = 79) 88% (n = 95) 12% (n = 13) 45 (13.5) (20-87) (n = 108)
All (n = 215) 26% (n = 55) 74% (n = 160) 89% (n = 192) 11% (n = 23) 45 (12.8) (16-87) (n = 215)
v2 = 0.895, p = 0.344a v2 = 1.843, p = 0.175b Z = 0.290, p = 0.772c
a Pearson’s Chi-square (df = 1) between all affected and non-affected, bPearson’s Chi-square (df = 1) between all females and males, cMann–
Whitney to test age
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Questionnaire three
Experience of information and recommendations
In general, the participants responding to this item were
satisfied with the information and with having undergone
genetic counseling and they were willing to recommend
genetic counseling to relatives. They were least satisfied
with ‘‘having received recommendations on cancer pre-
vention and surveillance’’ (Fig. 4.) A total of 32% (n = 43)
were not satisfied. The type of OGNC, affected status, age,
gender or on whose initiative the participants were referred
did not predict the outcomes on any of the items.
Worry of developing cancer
No significant difference in cancer worry between partici-
pants in the two OGNC groups was shown (Table 2). In
both OGNC groups, non-affected participants’ cancer
worry decreased during the study period. The reduction in
cancer worry was significant between the first and the
second assessment point (p \ 0.005, t = 3.13) No differ-
ence was found between the second and the third point of
assessment. In both OGNC groups, affected participants
showed no significant difference in cancer worry between
the first and second, or between the second and the third
assessment point.
Fig. 2 Experience with the
process of creating a pedigree
by group
Fig. 3 Satisfaction by group
after counseling and at 1 year
follow-up
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SF-36
The affected participants reported lower levels in most of
the SF-36 domains compared to non-affected at all three
points of assessment (Fig. 5). No statistical significant
differences in HRQoL were found between the two OGNC
groups.
Both affected and non-affected participants reported
lower levels in most of the domains as compared to a
Swedish reference group. The reported scores in all
domains improved over time for all participants and almost
reached the level of the reference group.
Discussion
When designing this study there was a preconception that
patients might prefer and benefit from traditional in-person
OGNC versus telephone OGNC. The results, however,
provide no support for this presumption as no differences
between the two methods of counseling were found. In
both post-counseling questionnaires all investigated areas:
participants’ expectations, satisfaction and experiences of
genetic counseling, worry for developing hereditary cancer
and quality of life according to SF-36 showed equal
outcomes in both groups. Over time a high satisfaction rate
was demonstrated in the two groups.
Interestingly 1 of 10 participants who were referred on
the initiative of their physician did not have any expecta-
tions regarding genetic counseling, suggesting that more
pre-counseling education may benefit these patients.
Creating a pedigree is the initial part of the oncogenetic
counseling process where the participants have an active
role in collecting information from relatives. Our study
indicates that almost half of the participants found it dif-
ficult to contact relatives and a fifth did not appreciate
learning about their families. One in ten of the participants
found it emotionally difficult to expose themselves and
their family and may have benefited from increased emo-
tional support from the caregivers. This is in accordance
with other studies stating that 20-40% of the patient desire
more emotional support during the counseling process
[1, 5]. Further, our study indicates that the dissatisfaction
with the lack of emotional support was most pronounced
among the young non-affected participants and with those
diagnosed with low or moderate risk of developing
hereditary cancer.
Information on recommended preventive actions seems
to be an area for improvement in oncogenetic counseling,
since as many as 33% of non-affected and 26% of affected
Fig. 4 Experience related to
information and
recommendations 1 year after
genetic investigations by group
Table 2 Cancer worry before and after counseling and 1 year after genetic investigations by cancer status by group
Before OGNC After OGNC pa, zc 1 year after pb, zc
In-person counseling
Non-affected participants 4.8 (n = 74) 4.0 (n = 50) p \ 0.005 z = -2.98 3.9 (n = 50) p = 0.576 z = -0.58
Affected participants 5.2 (n = 26) 5.0 (n = 16) p = 0.786 z = -0.43 5.4 (n = 15) p = 0.500 z = -0.82
Telephone counseling
Non-affected participants 4.8 (n = 73) 4.1 (n = 63) p \ 0.005 z = -4.2 3.8 (n = 59) p = 0.547 z = -0.61
Affected participants 4.9 (n = 23) 5.1 (n = 14) p = 0.217 z = -1.38 4.7 (n = 15) p = 0.845 z = -0.23
pa Between before genetic counseling and immediately after OGNC
pb Between immediately after OGNC and 1 year after genetic counseling process
zc Wilcoxon matched pairs
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participants were dissatisfied with information on advice
and recommendations. Again, our results indicate that the
dissatisfaction was most pronounced among non-affected
with low or moderate risk of developing cancer. In addition
to cancer specific surveillance, patients often ask for advice
concerning lifestyle factors affecting cancer risk. However,
lack of scientific evidence on risk reducing lifestyle factors
makes it difficult to meet this expectation.
In congruence with a study from Pieterse et al. [5], the
levels of cancer worry in affected participants remained
constant during the study period, while in non-affected the
levels declined. Cancer worry was not dependent on the
mode of counseling i.e. telephone or in-person counseling.
Risk perception over time did not differ between the
OGNC groups, supporting equal comprehensive outcomes
between groups (data not shown).
A weakness in our study is that genetic testing was not a
variable. Genetic testing was performed in a minority of
the participants and might have influenced the outcomes.
However, in a previous study by Arver et al. [18] psy-
chosocial effects of pre-symptomatic testing for breast/
ovarian and colon cancer predisposing genes were evalu-
ated. With the exception of the vitality domain of SF-36, no
statistical differences between carriers and non-carriers
were found in that study. Therefore, outcome of genetic
testing was not a variable in the current study.
When comparing participants’ data with reference data,
we found lower scores among participants in most of the
domains in the SF-36 questionnaire before OGNC. This
probably indicates that the family situation with cancer
disease and worry of increased risk for cancer influence
participants’ HRQoL. The participants may also be anxious
about the outcome of the investigations. The scores
improved over time and possible explanations are that
participants processed and defused their anxiety through
tools gained during the counseling process. Due to
administrative failure, the last page of SF-36 Health Survey
was missing in two-thirds of the third questionnaire,
making the results for domains GH, VT, SF and MH dif-
ficult to interpret, since only 28 responses were obtained
from the total of 141 participants responding to the last
questionnaire.
In total only 15% of the referred participants declined
participation in the questionnaire study, indicating a highly
motivated population. Non-participants were equally dis-
tributed between telephone and in-person OGNC, speaking
in favor of an unbiased cohort.
One of the strengths of this study is that one and the
same oncogenetic nurse conducted both telephone and in-
person OGNC and that this part of the counseling process
was well defined. Another important strength of the study
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Fig. 5 SF-36 scores by cancer status before and after genetic counselling and 1 year after genetic investigations
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third important aspect is that several cancer syndromes are
represented in participants which increases applicability to
clinical patient groups. One limitation however is that it is
difficult to fully separate participants satisfaction with the
OGNC from satisfaction with the entire genetic counseling
process as questionnaire number two and three were dis-
tributed after OGNC and physician counseling. The use of
questionnaires, developed to be study specific, but not
tested for reliability or validity is another limitation.
However, the questionnaires were tested for feasibility in a
small sample of patients.
Conclusions
Overall, a high satisfaction rate with the oncogenetic
counseling process was found among the participants
regardless of if the oncogenetic nurse counseling was
conducted by telephone or in-person.
Given the results of our study, the option of a pre-coun-
seling telephone model could be an equal or even better
alternative to in-person counseling and could very well be a
standard mode in the future. The results show that a con-
siderable number of participants experienced difficulties
with the process of creating a pedigree and dissatisfaction
with information on recommended surveillance and pre-
vention. These items should be areas of improvement.
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